Notice Title

Consent to the Distribution of New Medicines

Publication Date
5 Jun 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go2961
Title
View PDF
File Type and Size
PDF (39 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines are set out in the Schedule hereto:

Schedule

Product: Bortezomib Eugia
Active Ingredient: Bortezomib 3.5mg
Dosage Form: Powder for injection
New Zealand Sponsor: CARSL Consulting
Manufacturer: Eugia Pharma Specialities Limited, Medchal - Malkajgiri, India
   
Product: Dapsomed
Active Ingredient: Dapsone 50mg
Dosage Form: Tablet
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Dapsomed
Active Ingredient: Dapsone 100mg
Dosage Form: Tablet
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Dapsone (Medsurge)
Active Ingredient: Dapsone 50mg
Dosage Form: Tablet
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Dapsone (Medicianz)
Active Ingredient: Dapsone 50mg
Dosage Form: Tablet
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Dapsone (Medsurge)
Active Ingredient: Dapsone 100mg
Dosage Form: Tablet
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Dapsone (Medicianz)
Active Ingredient: Dapsone 100mg
Dosage Form: Tablet
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Rivopharm SA, Manno, Switzerland
   
Product: Neutrogena T/Gel Salicylic Acid 3% w/w Shampoo
Active Ingredient: Salicylic acid 3%w/w
Dosage Form: Shampoo
New Zealand Sponsor: JNTL Consumer Health (New Zealand) Limited
Manufacturer: Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Sitagliptin/Metformin Sandoz 50/1000
Active Ingredients: Metformin hydrochloride 1000mg
Sitagliptin hydrochloride monohydrate 56.685mg equivalent to 50mg sitagliptin
Dosage Form: Film coated tablet
New Zealand Sponsor: Sandoz New Zealand Limited
Manufacturer: Lek S.A., Strykow, Poland
   
Product: Sitagliptin/Metformin Sandoz 50/500
Active Ingredients: Metformin hydrochloride 500mg
Sitagliptin hydrochloride monohydrate 56.685mg equivalent to 50mg sitagliptin
Dosage Form: Film coated tablet
New Zealand Sponsor: Sandoz New Zealand Limited
Manufacturer: Lek S.A., Strykow, Poland
   
Product: Sitagliptin/Metformin Sandoz 50/850
Active Ingredients: Metformin hydrochloride 850mg
Sitagliptin hydrochloride monohydrate 56.685mg equivalent to 50mg sitagliptin
Dosage Form: Film coated tablet
New Zealand Sponsor: Sandoz New Zealand Limited
Manufacturer: Lek S.A., Strykow, Poland


Dated this 29th day of May 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).